CellCept
Sponsors
Mayo Clinic, University of Pittsburgh, Astellas Pharma Inc, Baylor Research Institute, Columbia University
Conditions
Acute Myeloid LeukemiaCarcinoma, HepatocellularChronic Lymphocytic LeukemiaChronic Myeloid LeukemiaDelayed Graft FunctionHealthy VolunteersImmunosuppressionKidney Transplantation
Phase 1
Phase 2
Phase 3
Comparison of Standard Versus Low Dose Advagraf® With or Without Angiotensin-converting Enzyme Inhibitor (ACEi)/Angiotensin Receptor Blocker (ARB) on Histology and Function of Renal Allografts
CompletedNCT00933231
Start: 2009-08-17End: 2018-04-03Updated: 2024-11-01
Haploidentical Allogeneic Peripheral Blood Transplantation: Examining Checkpoint Immune Regulators' Expression
Active, not recruitingNCT03480360
Start: 2018-03-28End: 2026-10-17Updated: 2026-02-19
Phase 4
A Kidney Transplant Study to Look at the Effects of Taking Fixed Doses of CellCept Versus Taking Doses of CellCept Based on the Concentration of CellCept in the Blood When Taking Full or Reduced Dose Calcineurin Inhibitors
TerminatedNCT00217152
Start: 2005-03-31End: 2007-08-31Updated: 2011-12-19
A Study to Compare Early Steroid Withdrawal and Long-Term Steroid Maintenance Therapy in Kidney Transplant Patients
CompletedNCT00650468
Start: 1999-11-30End: 2007-12-31Updated: 2011-11-17
Safety and Efficacy of Everolimus Treatment in Liver Transplantation for Liver Cancer
Enrolling by invitationNCT02081755
Start: 2014-03-01End: 2027-03-01Target: 336Updated: 2026-01-27
ACTHar in the Treatment of Lupus Nephritis
TerminatedNCT02226341
Start: 2014-10-31End: 2024-01-03Updated: 2025-03-07
Unknown Phase
A Prospective Study on the Tolerability and Efficacy of the de Novo Use of Myfortic in Liver Transplant Recipients
CompletedNCT00336817
Start: 2006-11-30End: 2008-11-30Updated: 2017-03-09
A Pharmacoeconomic Study Comparing the Use of Mycophenolate Mofetil or Cyclophosphamide as Induction Therapy in Lupus Nephritis Patients in Egypt
CompletedNCT05195086
Start: 2018-07-01End: 2021-06-05Updated: 2022-01-18